Applicability of the evidence regarding intensive glycemic control and self-monitored blood glucose to Medicare patients with type 2 diabetes

This technology assessment report on intensive glycemic control and self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus is prepared by the Tufts-New England Medical Center Evidence-based Practice Center (Tufts-NEMC EPC) for a Medicare Evidence Development and Coverage A...

Full description

Main Author: Balk, Ethan
Corporate Authors: United States Agency for Healthcare Research and Quality, Tufts Evidence-based Practice Center
Format: eBook
Language:English
Published: Rockville, Maryland Agency for Healthcare Research and Quality 2007, Sepember 10, 2007
Series:Technology assessment report
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:This technology assessment report on intensive glycemic control and self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus is prepared by the Tufts-New England Medical Center Evidence-based Practice Center (Tufts-NEMC EPC) for a Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meeting. The primary goal of the report is to describe the applicability of the larger, long-duration studies to the nondialysis Medicare population (i.e., people at least 65 years old). The specific questions addressed are described in the Methods chapter (Chapter 2). The Center for Medicare and Medicaid Services (CMS) also requested a brief narrative review of diabetes (both type 1 and type 2), its epidemiology in the US, complications due to the disease and its treatment, intensive glycemic control, and patient monitoring of glycemia
Item Description:Title from PDF title page
Physical Description:1 online resource (1 PDF file (83 pages))